TAK Takeda Pharmaceutical Company Limited American Depositary Shares Loading...

From CRM earnings calls
Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
22:00
Feb 25 ◎
Marc Benioff CEO, Salesforce, Inc. CRM Q4 FY26 call
Takeda is consolidating on Salesforce for life sciences, moving away from Microsoft's Viva.
TAK
HIGH

About TAK Analyst Coverage

Buzzberg tracks TAK (Takeda Pharmaceutical Company Limited American Depositary Shares) across 1 sources. 0 bullish vs 0 bearish calls from 1 analysts. Sentiment: evenly split. 1 total trade idea tracked. Latest voices: Marc Benioff.